Adalimumab persistence and its biosimilar in inflammatory bowel disease: experience in a tertiary centre

Cano, M. C. FernandezSanchez-Capilla, A. D.Martin-Rodriguez, M. M.Cabello-Tapia, M. J.Redondo-Cerezo, E.2025-01-072025-01-072021-05-011873-9946https://hdl.handle.net/10668/26285enAdalimumab persistence and its biosimilar in inflammatory bowel disease: experience in a tertiary centreconference outputopen access10.1093/ecco-jcc/jjab076.6511876-4479https://academic.oup.com/ecco-jcc/article-pdf/15/Supplement_1/S505/38317457/jjab076.651.pdf709432400652